Key result
Adapted 1 mL urinary 11-dehydro-TXB2 assay achieves 0.98 correlation with original method and 6-day stability.
Why the study?
The need for large urine volumes and unknown stability of urinary 11-dehydro-TXB2 after collection limit its implementation as a cardiovascular biomarker.
Urinary 11-dehydro-TXB2 can be reliably measured in 1 mL urine volumes and is stable at room temperature for up to 6 days, facilitating its use as a biomarker in large cardiovascular trials.
Answers are grounded in this paper and cite their sources.
May simplify urine collection for 11-dehydro-TXB2 assessment in large CV trials; leaves open clinical utility pending prospective validation.
BACKGROUND: Thromboxane (TX) A2 is a pro-thrombotic prostanoid synthesized by activated platelets, biotransformed into 11-dehydro-TXB2, measurable in urines. Eleven-dehydro-TXB2 excretion is increased in high risk cardiovascular diseases; however, this cardiovascular biomarker awaits validation in large trials. The need of large urine volume (8 - 10 mL) and the unknown stability of 11-dehydro-TXB2 in urine after collection might limit its implementation. METHODS: We scaled the original method for urine extraction and 11-dehydro-TXB2 measurement down to 1 mL, and assessed its stability at 4 degrees C or 25 degrees C up to 6 days after collection. The sensitivity of the 1 mL procedure was also tested in aspirin-treated patients with low 11-dehydro-TXB2 excretion RESULTS: The 1 mL adapted method was highly correlated with the original assay (rho = 0.98, p < 0.001, n = 33). Both methods showed similar recoveries in samples spiked with exogenous 11-dehydro-TXB2. Urinary 11-dehydro-TXB2 values in samples immediately frozen were comparable and highly correlated to values in samples at 4 degrees C (day 6: rho = 0.99, p > 0.001, n = 8) or 25 degrees C (day 6: rho = 0.98, p < 0.001, n = 23) up to 6 days in controls and patients. CONCLUSIONS: Eleven-dehydro-TXB2 can be measured in small urine volumes and is relatively stable for a few days after collection, even at 25 degrees C. These data allow the validation of this non-invasive cardiovascular biomarker in large studies.
No takes yet. Share an insight, caveat, or question.
Pagliaccia et al. (2013) studied Controls and aspirin-treated patients. 1 mL adapted method for urine extraction and 11-dehydro-TXB2 measurement vs. Original method (8-10 mL) was evaluated on Correlation between 1 mL adapted method and original assay (rho = 0.98, p=< 0.001). The 1 mL adapted method for measuring urinary 11-dehydro-TXB2 was highly correlated with the original assay and showed stability up to 6 days at 25 degrees C.
Synapse has enriched 10 related papers. Consider them for comparative context: